Difference between revisions of "Laura Shawver"
From QueerBio.com
| Line 14: | Line 14: | ||
==Description== | ==Description== | ||
| − | Chief Executive Officer of biotech company Silverback Therapeutics, a cancer drug developer, since 2020. Member of the Board of Directors of Relay Therapeutics. Pharmacologist. Formerly CEO with Phenomix, Cleave Therapeutics and Synthorx, and with Sugen. Founder of the Clearity Foundation for women with cancer. | + | Chief Executive Officer of biotech company Silverback Therapeutics, a cancer drug developer, since 2020. Member of the Board of Directors of Relay Therapeutics. Pharmacologist. Chair of the Board of Adcendo. Formerly CEO with Phenomix, Cleave Therapeutics and Synthorx, and with Sugen. Founder of the Clearity Foundation for women with cancer. |
==See Also== | ==See Also== | ||
Latest revision as of 20:11, 4 April 2025
Contents
[hide]Country
United States
Birth - Death
Occupation
Business
Description
Chief Executive Officer of biotech company Silverback Therapeutics, a cancer drug developer, since 2020. Member of the Board of Directors of Relay Therapeutics. Pharmacologist. Chair of the Board of Adcendo. Formerly CEO with Phenomix, Cleave Therapeutics and Synthorx, and with Sugen. Founder of the Clearity Foundation for women with cancer.
See Also
- LGBTQ Cancer Research and Support
- LGBTQ Chief Executive Officers of Business Enterprises
- LGBTQ Participants in Pharmaceutical, Vaccine and Biotech Studies
Further Reading/Research
- https://www.linkedin.com/in/laura-shawver-9319a87a/
- https://silverbacktx.com/team/laura-shawver-ph-d/
- https://endpts.com/a-longtime-laura-shawver-fan-calls-the-serial-entrepreneur-back-to-the-helm-of-a-biotech-upstart/
- https://www.businesswire.com/news/home/20200422005178/en/Silverback-Therapeutics-Announces-Appointment-of-Veteran-Executive-Laura-Shawver-Ph.D.-as-President-and-CEO
